These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Evaluation of Combined p57KIP2 Immunohistochemistry and Fluorescent in situ Hybridization Analysis for Hydatidiform Moles Compared with Genotyping Diagnosis. Usui H; Hoshimoto K; Sato A; Kano M; Fukusato T; Nakatani Y; Shozu M Int J Gynecol Pathol; 2024 Sep; 43(5):474-486. PubMed ID: 38291567 [TBL] [Abstract][Full Text] [Related]
24. P57KIP2 immunostaining and molecular cytogenetics: combined approach aids in diagnosis of morphologically challenging cases with molar phenotype and in detecting androgenetic cell lines in mosaic/chimeric conceptions. Hoffner L; Dunn J; Esposito N; Macpherson T; Surti U Hum Pathol; 2008 Jan; 39(1):63-72. PubMed ID: 17904617 [TBL] [Abstract][Full Text] [Related]
25. DNA Genotyping of Nonmolar Donor Egg Pregnancies With Abnormal Villous Morphology: Allele Zygosity Patterns Prevent Misinterpretation as Complete Hydatidiform Mole. Joseph NM; Pineda C; Rabban JT Int J Gynecol Pathol; 2018 Mar; 37(2):191-197. PubMed ID: 28463912 [TBL] [Abstract][Full Text] [Related]
26. Tetraploid partial hydatidiform mole: a case report and review of the literature. Murphy KM; Descipio C; Wagenfuehr J; Tandy S; Mabray J; Beierl K; Micetich K; Libby AL; Ronnett BM Int J Gynecol Pathol; 2012 Jan; 31(1):73-9. PubMed ID: 22123726 [TBL] [Abstract][Full Text] [Related]
27. Clinical utility of selective molecular genotyping for diagnosis of partial hydatidiform mole; a retrospective study from a regional trophoblastic disease unit. Fisher RA; Tommasi A; Short D; Kaur B; Seckl MJ; Sebire NJ J Clin Pathol; 2014 Nov; 67(11):980-4. PubMed ID: 25078332 [TBL] [Abstract][Full Text] [Related]
28. Comprehensive genotype-phenotype correlations between NLRP7 mutations and the balance between embryonic tissue differentiation and trophoblastic proliferation. Nguyen NM; Zhang L; Reddy R; Déry C; Arseneau J; Cheung A; Surti U; Hoffner L; Seoud M; Zaatari G; Bagga R; Srinivasan R; Coullin P; Ao A; Slim R J Med Genet; 2014 Sep; 51(9):623-34. PubMed ID: 25097207 [TBL] [Abstract][Full Text] [Related]
29. Metastatic trophoblastic disease after an initial diagnosis of partial hydatidiform mole: genotyping and chromosome in situ hybridization analysis. Cheung AN; Khoo US; Lai CY; Chan KY; Xue WC; Cheng DK; Chiu PM; Tsao SW; Ngan HY Cancer; 2004 Apr; 100(7):1411-7. PubMed ID: 15042675 [TBL] [Abstract][Full Text] [Related]
30. Rare Complete Hydatidiform Mole With p57 Expression in Villous Mesenchyme: Case Report and Review of Discordant p57 Expression in Hydatidiform Moles. Murphy KM; Carrick K; Gwin K; Rogers V; Koduru P; Ronnett BM; Castrillon DH Int J Gynecol Pathol; 2022 Jan; 41(1):45-50. PubMed ID: 33900230 [TBL] [Abstract][Full Text] [Related]
31. A novel NLRP7 protein-truncating mutation associated with discordant and divergent p57 immunostaining in diploid biparental and triploid digynic moles. Allias F; Mechtouf N; Gaillot-Durand L; Hoffner L; Hajri T; Devouassoux-Shisheboran M; Massardier J; Golfier F; Bolze PA; Surti U; Slim R Virchows Arch; 2020 Aug; 477(2):309-315. PubMed ID: 32055942 [TBL] [Abstract][Full Text] [Related]
32. Auxiliary and experimental diagnostic techniques for hydatidiform moles. Usui H J Obstet Gynaecol Res; 2022 Dec; 48(12):3077-3086. PubMed ID: 36098274 [TBL] [Abstract][Full Text] [Related]
33. Single-nucleotide polymorphism array and fluorescence in situ hybridization analysis to decode the cytogenetic profile of atypical partial hydatidiform moles diagnosed by short tandem repeat polymorphism analysis. Suzuki Y; Usui H; Katayama E; Sato A; Nakamura N; Nakada E; Omoto A; Okayama J; Sato M; Nagasawa A; Hirosawa A; Shozu M; Koga K Genes Chromosomes Cancer; 2024 Feb; 63(2):e23220. PubMed ID: 38780072 [TBL] [Abstract][Full Text] [Related]
35. [Expression of p57 marker in differential diagnosis of complete and partial mole - correlation with DNA analysis]. Cierna Z; Palkovič M; Danihel Ml L; Danihel L; Repiská V; Vojtaššák J; Korbeľ M Cesk Patol; 2012 Oct; 48(4):218-21. PubMed ID: 23121032 [TBL] [Abstract][Full Text] [Related]
36. Mutations in NLRP7 and KHDC3L confer a complete hydatidiform mole phenotype on digynic triploid conceptions. Fallahian M; Sebire NJ; Savage PM; Seckl MJ; Fisher RA Hum Mutat; 2013 Feb; 34(2):301-8. PubMed ID: 23125094 [TBL] [Abstract][Full Text] [Related]
37. "While there is p57, there is hope." The past and the present of diagnosis in first trimester abortions: Diagnostic dilemmas and algorithmic approaches. A review. Giacometti C; Bellan E; Ambrosi A; Dei Tos AP; Cassaro M; Ludwig K Placenta; 2021 Dec; 116():31-37. PubMed ID: 33714612 [TBL] [Abstract][Full Text] [Related]
38. Gestational Trophoblastic Neoplasia From Genetically Confirmed Hydatidiform Moles: Prospective Observational Cohort Study. Usui H; Qu J; Sato A; Pan Z; Mitsuhashi A; Matsui H; Shozu M Int J Gynecol Cancer; 2018 Nov; 28(9):1772-1780. PubMed ID: 30358702 [TBL] [Abstract][Full Text] [Related]
39. Incidence of postmolar gestational trophoblastic disease in androgenetic moles and the morphological features associated with low risk postmolar gestational trophoblastic disease. Kaneki E; Kobayashi H; Hirakawa T; Matsuda T; Kato H; Wake N Cancer Sci; 2010 Jul; 101(7):1717-21. PubMed ID: 20518791 [TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical characterization of p57Kip2 expression in tetraploid hydropic placentas. Fukunaga M Arch Pathol Lab Med; 2004 Aug; 128(8):897-900. PubMed ID: 15270611 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]